Ji E. Jun

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Dulaglutide versus empagliflozin as add-on therapy to metformin and sulfonylurea in type 2 diabetes: a randomized pilot study with exploratory metabolomic and microbiome analyses.

Dulaglutide versus empagliflozin as add-on therapy to metformin and sulfonylurea in type 2 diabetes: a randomized pilot study with exploratory metabolomic and microbiome analyses.

Journal: Frontiers in endocrinology

Published: March 31, 2026

Dementia Risk in Type 1 and 2 Diabetes: A Nationwide Population-Based Comparison.

Dementia Risk in Type 1 and 2 Diabetes: A Nationwide Population-Based Comparison.

Journal: Diabetes, obesity & metabolism

Published: February 01, 2026

Burden of End-Stage Kidney Disease by Type 2 Diabetes Mellitus Status in South Korea: A Nationwide Epidemiologic Study (Diabetes Metab J 2025;49:498-506).

Burden of End-Stage Kidney Disease by Type 2 Diabetes Mellitus Status in South Korea: A Nationwide Epidemiologic Study (Diabetes Metab J 2025;49:498-506).

Journal: Diabetes & metabolism journal

Published: September 11, 2025

TERT promoter mutations and recurrence patterns in differentiated thyroid carcinoma.

TERT promoter mutations and recurrence patterns in differentiated thyroid carcinoma.

Journal: Endocrine-related cancer

Published: July 22, 2025

Experiences of healthcare providers and patients with diabetes mellitus regarding continuous glucose monitoring use in South Korea: a multicenter, cross-sectional survey study.

Experiences of healthcare providers and patients with diabetes mellitus regarding continuous glucose monitoring use in South Korea: a multicenter, cross-sectional survey study.

Journal: Journal of Yeungnam medical science

Published: July 16, 2025

Income and risk of type 2 diabetes incidence varied associations according to obesity status: a nationwide study.

Income and risk of type 2 diabetes incidence varied associations according to obesity status: a nationwide study.

Journal: BMC public health

Published: June 28, 2025

EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study).

EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study).

Journal: Diabetes, obesity & metabolism

Published: March 18, 2025

Association of carotid atherosclerosis with brain tissue integrity and metabolic parameters in type 2 diabetes patients.

Association of carotid atherosclerosis with brain tissue integrity and metabolic parameters in type 2 diabetes patients.

Journal: Frontiers in endocrinology

Published: March 02, 2025

Improved Glycemic Control in Insulin-Treated Individuals With Poorly Controlled Type 2 Diabetes Through Combined Structured Education With Real-Time Continuous Glucose Monitoring.

Improved Glycemic Control in Insulin-Treated Individuals With Poorly Controlled Type 2 Diabetes Through Combined Structured Education With Real-Time Continuous Glucose Monitoring.

Journal: Journal of diabetes science and technology

Published: January 04, 2025

Association of Continuous Glucose Monitoring-Derived Glycemia Risk Index With Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus: A Cross-sectional Study.

Association of Continuous Glucose Monitoring-Derived Glycemia Risk Index With Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus: A Cross-sectional Study.

Journal: Journal of diabetes science and technology

Published: October 14, 2024

Discrepancies in Dapagliflozin Response in Terms of Glycemic Control and Body Weight Reduction.

Discrepancies in Dapagliflozin Response in Terms of Glycemic Control and Body Weight Reduction.

Journal: Endocrinology and metabolism (Seoul, Korea)

Published: August 18, 2024

A Compound Containing Aldehyde Dehydrogenase Relieves the Effects of Alcohol Consumption and Hangover Symptoms in Healthy Men: An Open-Labeled Comparative Study.

A Compound Containing Aldehyde Dehydrogenase Relieves the Effects of Alcohol Consumption and Hangover Symptoms in Healthy Men: An Open-Labeled Comparative Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 19, 2024

Showing 1-12 of 67

Last Updated: 09/26/2026